HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Garrido Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

5/2000Multiple mechanisms underlie HLA dysregulation in cervical cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Garrido Research Topics

Disease

19Neoplasms (Cancer)
08/2014 - 01/2000
5Melanoma (Melanoma, Malignant)
02/2007 - 01/2000
3Renal Cell Carcinoma (Grawitz Tumor)
04/2014 - 10/2006
2Infections
12/2004 - 11/2002
2Brucellosis (Malta Fever)
06/2004 - 10/2000
2Colorectal Neoplasms (Colorectal Cancer)
05/2004 - 03/2003
2Carcinoma (Carcinomatosis)
09/2001 - 10/2000
1Prostatic Neoplasms (Prostate Cancer)
04/2014
1Liver Diseases (Liver Disease)
07/2008
1Hepatolenticular Degeneration (Wilson's Disease)
07/2008
1Breast Neoplasms (Breast Cancer)
01/2007
1Carcinogenesis
01/2007
1Acute Promyelocytic Leukemia
05/2004
1Leukemia
05/2004
1Fibrosarcoma
08/2001
1Neoplasm Metastasis (Metastasis)
06/2001
1Iron Deficiencies
07/2000
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2000

Drug/Important Bio-Agent (IBA)

8HLA Antigens (Human Leukocyte Antigens)IBA
08/2014 - 01/2000
8AntigensIBA
03/2012 - 06/2001
7Peptides (Polypeptides)IBA
08/2014 - 01/2000
5Histocompatibility Antigens Class IIBA
02/2010 - 01/2000
4Proteins (Proteins, Gene)FDA Link
04/2014 - 03/2003
3Monoclonal AntibodiesIBA
02/2010 - 10/2000
3CytokinesIBA
10/2006 - 03/2000
3HLA-A Antigens (HLA-A)IBA
03/2003 - 09/2001
3DNA (Deoxyribonucleic Acid)IBA
08/2001 - 10/2000
2HLA-DR Antigens (HLA-DR)IBA
02/2010 - 02/2007
2EnzymesIBA
08/2001 - 10/2000
2HLA-A2 Antigen (HLA A2 Antigen)IBA
06/2001 - 10/2000
1Neoplasm Antigens (Tumor Antigens)IBA
08/2014
1ParaffinIBA
02/2010
1CopperIBA
07/2008
1Methionine (L-Methionine)FDA Link
07/2008
1S-Adenosylmethionine (Ademetionine)IBA
07/2008
1MHC class II transactivator proteinIBA
02/2007
1Histocompatibility Antigens Class IIIBA
02/2007
1HLA-DP Antigens (HLA-DP)IBA
02/2007
1HLA-DQ Antigens (HLA-DQ)IBA
02/2007
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2007
1Malathion (Karbofos)FDA LinkGeneric
01/2007
1PhysostigmineIBA
01/2007
1Estradiol (Delestrogen)FDA LinkGeneric
01/2007
1Hormones (Hormone)IBA
01/2007
1Parathion (Ethyl Parathion)IBA
01/2007
1InterferonsIBA
10/2006
1Interferon-gamma (Interferon, gamma)IBA
10/2006
1Messenger RNA (mRNA)IBA
10/2006
1Interleukin-10 (Interleukin 10)IBA
10/2006
1ChemokinesIBA
10/2006
1Chemokine CCL5IBA
10/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2006
1Vascular Endothelial Growth Factor CIBA
10/2006
1Chemokine CXCL11IBA
10/2006
1Chemokine CXCL12IBA
10/2006
1Chemokine CCL3IBA
10/2006
1AntibodiesIBA
06/2004
1Proteasome Endopeptidase Complex (Proteasome)IBA
05/2004
1Retinoic Acid Receptor alphaIBA
05/2004
1Complement System Proteins (Complement)IBA
11/2002
1Rose BengalIBA
11/2002
1DecitabineFDA Link
10/2001
1NucleotidesIBA
09/2001
1Biological ProductsIBA
08/2001
1AntioxidantsIBA
08/2001
1tert-ButylhydroperoxideIBA
08/2001
18-Hydroxy-2'-DeoxyguanosineIBA
08/2001
1Malondialdehyde (Propanedial)IBA
08/2001
1MethylcholanthreneIBA
08/2001
1ElementsIBA
06/2001
1MART-1 AntigenIBA
06/2001
1Monophenol Monooxygenase (Tyrosinase)IBA
06/2001
1ImmunosorbentsIBA
10/2000
1Hypoglycemic Agents (Hypoglycemics)IBA
07/2000
1Antihypertensive Agents (Antihypertensives)IBA
07/2000
1Anti-Bacterial Agents (Antibiotics)IBA
07/2000
1Terminator Codon (Termination Codon)IBA
01/2000
1Codon (Codons)IBA
01/2000

Therapy/Procedure

7Immunotherapy
08/2014 - 01/2000
3Therapeutics
06/2014 - 05/2000